Efficient implementation of RNA interference in the pathogenic yeast Cryptococcus neoformans

Journal of Microbiological Methods

Volumn 86, Issue 2, 2011, Pages 156-159

  Bose, Indrani ^a   Doering, Tamara L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cryptococcus neoformans; Pathogenic fungus; RNA interference

Indexed keywords

ARTICLE; CRYPTOCOCCUS NEOFORMANS; FUNGAL GENE; GENE SEQUENCE; GENE SILENCING; GENETIC VARIABILITY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; RNA INTERFERENCE; URA5 GENE;

CRYPTOCOCCUS NEOFORMANS; DNA, FUNGAL; GENETICS, MICROBIAL; HUMANS; MOLECULAR SEQUENCE DATA; PLASMIDS; RNA INTERFERENCE; SEQUENCE ANALYSIS, DNA;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 79959713978     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2011.04.014     Document Type: Article

References (17)

1. Boeke J.D., Trueheart J., Natsoulis G., Fink G.R. 5-Fluoroorotic acid as a selective agent in yeast molecular genetics. Methods Enzymol. 1987, 154:164-175.
2. Cox G.M., Rude T.H., Dykstra C.C., Perfect J.R. The actin gene from Cryptococcus neoformans: structure and phylogenetic analysis. J. Med. Vet. Mycol. 1995, 33:261-266.
3. Edman J.C., Kwon-Chung K.J. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol. Cell. Biol. 1990, 10:4538-4544.
4. Edman J.C. Isolation of telomeric sequences from Cryptococcus neoformans and their use in high-efficiency transformation. Mol. Cell. Biol. 1992, 12:2777-2783.
5. Janbon G., Maeng S., Yang D.H., Ko Y.J., Jung K.W., Moyrand F., Floyd A., Heitman J., Bahn Y.S. Characterizing the role of RNA silencing components in Cryptococcus neoformans. Fumgal Genet. Biol. 2010, 47:1070-1080.
6. Liu H., Cottrell T.R., Pierini L.M., Goldman W.E., Doering T.L. RNA interference in the pathogenic fungus Cryptococcus neoformans. Genetics 2002, 160:463-470.
7. Loftus B.J., et al. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 2005, 307:1321-1324.
8. McDade H.C., Cox G.M. A new dominant selectable marker for use in Cryptococcus neoformans. Med. Mycol. 2001, 39:151-154.
9. Nakayashiki H., Kadotani N., Mayama S. Evolution and diversification of RNA silencing proteins in fungi. J. Mol. Evol. 2006, 63:127-135.
10. Panepinto J., Komperda K., Frases S., Park Y.D., Djordjevic J.T., Casadevall A., Williamson P.R. Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Mol. Microbiol. 2009, 71:1165-1176.
11. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
12. Rappleye C.A., Engle J.T., Goldman W.E. RNA interference in Histoplasma capsulatum demonstrates a role for alpha-(1,3)-glucan in virulence. Mol. Microbiol. 2004, 53:153-165.
13. Reilly M.C., Levery S.B., Castle S.A., Klutts J.S., Doering T.L. A novel xylosylphosphotransferase activity discovered in Cryptococcus neoformans. J. Biol. Chem. 2009, 284:36118-36127.
14. Sudarshan S., Davidson R.C., Heitman J., Alspaugh J.A. Molecular analysis of the Cryptococcus neoformans ADE2 gene, a selectable marker for transformation and gene disruption. Fungal Genet. Biol. 1999, 27:36-48.
15. Tenney A.E., Brown R.H., Vaske C., Lodge J.K., Doering T.L., Brent M.R. Gene prediction and verification in a compact genome with numerous small introns. Genome Res. 2004, 14:2330-2335.
16. Wickes B.L., Edman J.C. The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter. Mol. Microbiol. 1995, 16:1099-1109.
17. Wickes B.L., Edman U., Edman J.C. The Cryptococcus neoformans STE12alpha gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating type specific. Mol. Microbiol. 1997, 26:951-960.